How many stocks are there of Spineway?
The current number of stocks of Spineway is 71,510 undefined.
Spineway Stocks 2024
Spineway Stocks
71,510
Ticker
ALSPW.PA
ISIN
FR0011398874
WKN
A1KCX1
In 2024, Spineway had 71,510 outstanding stocks, a 0% change from the 71,510 stocks in the previous year.
The Spineway Stocks history
| YEAR | NUMBER OF STOCKS (undefined EUR) |
|---|---|
| 2024e | 0.07 |
| 2023 | 0.07 |
| 2022 | 0 |
| 2021 | 0 |
| 2020 | 0.04 |
| 2019 | 0 |
| 2018 | 0 |
| 2017 | 0 |
| 2016 | 0 |
| 2015 | 3.51 |
| 2014 | 3.56 |
| 2013 | 3.4 |
| 2012 | 2.8 |
| 2011 | 2.8 |
Spineway shares outstanding FR0011398874 · A1KCX1
The number of shares was Spineway in 2023 — This indicates how many shares 71,510 is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.
3 years
5 years
10 years
25 Years
Max
Number of stocks
Details
Revenue, EBIT and Earnings per share
ⓘRevenue Per Share
Revenue per share represents the total revenue Spineway earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.
EBIT Per Share
EBIT per share indicates Spineway's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.
Income Per Share
Income per share, or earnings per share (EPS), reveals the portion of Spineway’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.
Expected Values
Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Spineway's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.
| Number of stocks | |
|---|---|
| 2011 | 2.8 M Aktien |
| 2012 | 2.8 M Aktien |
| 2013 | 3.4 M Aktien |
| 2014 | 3.56 M Aktien |
| 2015 | 3.51 M Aktien |
| 2016 | 110 Aktien |
| 2017 | 110 Aktien |
| 2018 | 150 Aktien |
| 2019 | 1,120 Aktien |
| 2020 | 40,740 Aktien |
| 2021 | 170 Aktien |
| 2022 | 1,820 Aktien |
| 2023 | 71,510 Aktien |
| 2024e | 71,510 Aktien |
Spineway Aktienanalyse
What does Spineway do?
Spineway SA is an internationally active company specializing in the development and marketing of innovative solutions in the field of spinal surgery. The company was founded in France in 2005 and has since expanded its business to be present in over 40 countries. The business model of Spineway is based on strong research and development capabilities as well as a close network of partners such as hospitals and surgeons. The goal is to continuously analyze the needs of patients and the challenges of modern spinal surgery and develop innovative solutions that enable doctors to perform their work more precisely and safely. Spineway specializes in three main areas: instrumentation, biomaterials, and spinal health. It offers a wide range of instruments, from screws to implants, that can be used in the lumbar, thoracic, and cervical spine. The company works closely with surgeons to develop specific solutions and instruments that meet the individual needs of patients. In addition, Spineway develops and produces its own biomaterials, which are used in various products such as screws and cages that are implanted in the spine. The company has developed a customized production line to ensure the highest possible quality of its biomaterials. Spineway is also committed to improving spinal health through innovative solutions and patient and physician education. The company has developed various programs to raise awareness among patients about how to maintain and improve the health of their spine. Some of Spineway's most well-known products include spinal surgery solutions such as the Mont-Blanc All-in-One Steering and K-Fix Steering, as well as a wide range of cages and screws made from their own biomaterials. Additionally, Spineway has developed products for the transplantation of cartilage and connective tissue. Over the years, Spineway has achieved several important milestones. The company has been listed on the Paris Stock Exchange since 2011 and has expanded its global presence in recent years through the opening of subsidiaries in the US, Mexico, and Brazil, as well as strategic partnerships in Asia and the Middle East. In summary, Spineway holds a leading position in the spinal surgery market and continues to focus on constantly searching for innovative solutions to maximize returns for its investors and improve the lives of patients. Spineway ist eines der beliebtesten Unternehmen auf Eulerpool.com.Stocks Details
Evaluating Spineway's Shares Outstanding
Spineway's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.
Year-to-Year Comparison
Tracking the changes in Spineway’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.
Impact on Investments
For investors, understanding Spineway’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.
Interpreting Changes in Shares Outstanding
Variances in Spineway’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.
Frequently Asked Questions about Spineway stock
What does Number of Shares / OutstandingShares mean?
The outstanding shares (or issued shares) of Spineway are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.
How has the number of shares of Spineway evolved in recent years?
The number of shares of Spineway has increased by 0% gestiegen compared to last year.
What does the number of shares mean for investors?
The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.
Why does the number of stocks fluctuate?
There are various factors that can lead to a change. Spineway as a company can issue new shares, carry out stock splits or reverse splits.
Does the number of shares have an impact on the performance of Spineway?
There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
How much dividend does Spineway pay?
Over the past 12 months, Spineway paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Spineway is expected to pay a dividend of 0 EUR.
What is the dividend yield of Spineway?
The current dividend yield of Spineway is .
When does Spineway pay dividends?
Spineway pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Spineway?
Spineway paid dividends every year for the past 0 years.
What is the dividend of Spineway?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is Spineway located?
Spineway is assigned to the 'Health' sector.
Wann musste ich die Aktien von Spineway kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Spineway from 11/9/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 11/9/2024.
When did Spineway pay the last dividend?
The last dividend was paid out on 11/9/2024.
What was the dividend of Spineway in the year 2023?
In the year 2023, Spineway distributed 0 EUR as dividends.
In which currency does Spineway pay out the dividend?
The dividends of Spineway are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Spineway
Our stock analysis for Spineway Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Spineway Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
